PTK2 and breast carcinoma: Therefore, deepening the molecular mechanisms involved in the action of FAK as a mechanotransducer would facilitate the identification of novel agents able to prevent the biomechanical adjustments of breast cancer cells upon the mechanical forces and their stimulation within the TME.